Trading Signals: FGEN Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)(FibroGen Inc.)
| FGEN latest price $17.9500 (1.13%) ($17.7500 - $18.6500) on Tue. Oct. 18, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.89% (three month average) | RSI | 18 | Latest Price | $17.9500(1.13%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FGEN declines -1.8% a day on average for past five trading days. | Weekly Trend | FGEN declines -7.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support FGEN advance at 0% a week (0% probability) XBI(36%) IBB(31%) IWO(27%) XLV(27%) IWC(26%) | Factors Impacting FGEN price | FGEN will decline at least -1.445% in a week (0% probabilities). VIXM(-10%) UUP(-10%) TLT(-8%) IPO(-3%) TIP(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.445% (StdDev 2.89%) | Hourly BBV | 0 () | Intraday Trend | -1.4% | | | |
|
1 - 5 Day Possible Target | $4.45(-75.21%) | Resistance Level | $20.16 | 5 Day Moving Average | $17.94(0.06%) | 10 Day Moving Average | $18.96(-5.33%) | 20 Day Moving Average | $20.16(-10.96%) | To recent high | -20.1% | To recent low | 6.2% | Market Cap | $1.62b | | | | FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA. |